N 3 (188) 2024. P. 25–28

SHORT-TERM AND LONG-TERM RESULTS OF TRANSPERITONEAL AND RETROPERITONEAL ENDOSCOPIC ADRENALECTOMY FOR HORMONE-ACTIVE TUMORS OF THE ADRENAL GLANDS

R. S. Parfentiev, V. V. Slepov

Odesa National Medical University, Odesa, Ukraine

DOI 10.32782/2226-2008-2024-3-4

The purpose of the present paper was to conduct a comparative study of the short-term and long-term results of transabdominal laparoscopic adrenalectomy (TLA) and retroperitoneal adrenalectomy (RPA) to develop clear indications for the use of optimal methods of endoscopic adrenalectomy.

Materials and methods. A retrospective analysis of the results of endoscopic adrenalectomy was conducted in 472 patients, including 282 with hormone-active tumors of the adrenal glands, operated in 2000–2021 at the Odesa Regional Hospital (Odesa, Ukraine). The mean age of the patients was (50.7±0.6) years, with a predominance of women (65.2%).

The results. The duration of surgical intervention in TLA group was (83.1±3.8) min, RPA group – (56.7±4.9) min (p<0.05). Blood loss in TLA group was (111±7) min, RPA group – (82±9) min (p<0.5). The need for conversion occurred in 8 (4.9%) cases in TLA group and in 3 (2.5%) cases in RPA group (p>0.05). Indicators of the quality of life in remote period after the operation were studied in 76 patients (43 of TLA group and 33 of RPА group). Our study proved that two years after the intervention the quality of life did not differ in patients of TLA and RPA groups (67.5 vs. 69.2 points).

Better results of quality of life in RPA group are achieved in patients with smaller hormone-active tumors (r = –0.63 p < 0.05). In TLA group, the dependence of quality of life on tumor size was lower (r = –0.34 p < 0.05).

Conclusions:

  1. The complications rate after RPA is much lower than after TLA.
  2. At the long-term period, the use of RPA is associated with a higher quality of life.
  3. Retroperitoneal adrenalectomy should be recommended as the method of choice for the surgical treatment of small hormone-active adrenal tumors.

Keywords: adrenal tumors, surgical treatment, endoscopic interventions, retroperitoneal access, quality of life.

BIBLIOGRAPHY

  1. Ebbehoj A, Li D, Kaur RJ, et al. Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. Lancet Diabetes Endocrinol. 2020; 8 (11): 894–902. doi:10.1016/S2213-8587(20)30314-4.
  2. Jing Y, Hu J, Luo R, et al. Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population. A Cross-Sectional Study. Ann Intern Med. 2022; 175 (10): 1383–1391. doi: 10.7326/M22-1619.
  3. Duh Quan-Yang. Understanding the epidemiology of adrenal tumours. The Lancet Diabetes & Endocrinology. 2020; 8 (11): 871–873. doi: 10.1016/S2213-8587(20)30335-1.
  4. Lee JM, Kim MK, Ko SH, et al. Clinical Guidelines for the Management of Adrenal Incidentaloma. Endocrinol Metab.2017; 32 (2): 200–218. doi: 10.3803/EnM.2017.32.2.200.
  5. Harris D., Wheeler M. History of Adrenal Surgery http://eknygos.lsmuni.lt/springer/10/0%201-6.pdf.
  6. Grubnik VV, Parfentiev RS, Grubnyk VV, Grubnik YV, Sliepov VV. Transabdominal and retroperitoneal adrenalectomy: comparative study. Surg Endosc. 2024; 38 (3): 1541–1547. doi: 10.1007/s00464-023-10533-9.
  7. Raffaelli M, De Crea C, Bellantone R. Laparoscopic adrenalectomy. Gland Surg. 2019; 8 (1): 41–52. doi: 10.21037/ gs.2019.06.07.
  8. Isiktas G, Akgun E, Berber E. Laparoscopic versus robotic lateral transabdominal adrenalectomy. J Surg Oncol. 2024; 129 (2): 224–227. doi: 10.1002/jso.27493.
  9. Uludağ M, Aygün N, İşgör A. Surgical Indications and Techniques for Adrenalectomy. Sisli Etfal Hastan Tip Bul. 2020; 54 (1): 8–22. doi: 10.14744/SEMB.2019.05578.
  10. Prudhomme T, Roumiguié M, Gas J, Soulié M, Thoulouzan M, Huyghe E. Comparison between retroperitoneal and transperitoneal laparoscopic adrenalectomy: Are both equally safe? J Visc Surg. 2021; 158 (3): 204–210. doi: 10.1016/j. jviscsurg.2020.07.009.
  11. Lee SYH, Wong C. Time to Flip the Approach: Retroperitoneoscopic Adrenalectomy. J Surg Res. 2024; 296: 189–195. doi: 10.1016/j.jss.2023.12.032.
  12. Corssmit EPM, Dekkers OM. Screening in adrenal tumors. Curr Opin Oncol. 2019; 31 (3): 243–246. doi: 10.1097/ CCO.0000000000000528.
  13. Matsuda T, Murota T, Kawakita M. Transperitoneal anterior laparoscopic adrenalectomy: the easiest technique. Biomed Pharmacother. 2000; 54 (1): 157–160. doi: 10.1016/s0753-3322(00)80034-7.
  14. Munver R, Ilbeigi P. Retroperitoneal laparoscopic adrenalectomy. Curr Urol Rep. 2005; 6 (1): 72–7. doi: 10.1007/ s11934-005-0070-x.
  15. Reed MD, Van Nostran W. Assessing pain intensity with the visual analog scale: a plea for uniformity. J Clin Pharmacol. 2014; 54 (3): 241–4. doi: 10.1002/jcph.250.
  16. Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med. 2016; 4: 2050312116671725. doi: 10.1177/2050312116671725.
  17. Fetisov VS. Paket statystychnoho analizu danykh STATISTICA: navch. posib. Nizhyn, NDU im. M. Hoholia, 2018; 114. (in Ukrainian).
View article PDF